Rani Therapeutics Holdings Inc banner

Rani Therapeutics Holdings Inc
NASDAQ:RANI

Watchlist Manager
Rani Therapeutics Holdings Inc Logo
Rani Therapeutics Holdings Inc
NASDAQ:RANI
Watchlist
Price: 1.38 USD
Market Cap: $167.7m

Profitability Summary

Rani Therapeutics Holdings Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Rani Therapeutics Holdings Inc

Margins Comparison
Rani Therapeutics Holdings Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Rani Therapeutics Holdings Inc
NASDAQ:RANI
167.7m USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
949.9B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.8B USD
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
267.4B CHF
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
226.4B GBP
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.9B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
292.8B USD
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.4B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Rani Therapeutics Holdings Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Rani Therapeutics Holdings Inc
NASDAQ:RANI
167.7m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
949.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
588.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
267.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
226.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
234.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
292.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.4B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Rani Therapeutics Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett